Viewing Study NCT06109233


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2025-12-29 @ 9:13 AM
Study NCT ID: NCT06109233
Status: RECRUITING
Last Update Posted: 2024-07-05
First Post: 2023-10-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment
Sponsor: FengYan Jin
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-01-10
Start Date Type: ACTUAL
Primary Completion Date: 2025-01-10
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-01-10
Completion Date Type: ESTIMATED
First Submit Date: 2023-10-16
First Submit QC Date: None
Study First Post Date: 2023-10-31
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-07-03
Last Update Post Date: 2024-07-05
Last Update Post Date Type: ACTUAL